Cutera, Inc. (NASDAQ:CUTR) EVP Ronald J. Santilli sold 1,068 shares of the firm’s stock in a transaction dated Tuesday, August 15th. The shares were sold at an average price of $33.20, for a total value of $35,457.60. Following the transaction, the executive vice president now owns 87,253 shares in the company, valued at $2,896,799.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Cutera, Inc. (NASDAQ CUTR) traded up 2.41% during trading on Wednesday, hitting $34.00. The stock had a trading volume of 215,897 shares. The company has a market capitalization of $476.17 million, a price-to-earnings ratio of 73.12 and a beta of 0.60. Cutera, Inc. has a 12-month low of $10.54 and a 12-month high of $34.91. The stock has a 50 day moving average price of $27.89 and a 200 day moving average price of $22.77.

Cutera (NASDAQ:CUTR) last issued its earnings results on Monday, August 7th. The medical device company reported $0.13 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.03 by $0.10. The company had revenue of $36.40 million for the quarter, compared to analysts’ expectations of $32.08 million. Cutera had a net margin of 5.35% and a return on equity of 13.05%. Cutera’s quarterly revenue was up 32.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.07 EPS. Equities research analysts forecast that Cutera, Inc. will post $0.52 earnings per share for the current year.

Cutera announced that its Board of Directors has initiated a share buyback plan on Monday, August 7th that permits the company to repurchase $25.00 million in outstanding shares. This repurchase authorization permits the medical device company to purchase up to 6.8% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s board believes its shares are undervalued.

ILLEGAL ACTIVITY WARNING: “Cutera, Inc. (CUTR) EVP Ronald J. Santilli Sells 1,068 Shares” was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this news story can be viewed at https://www.thecerbatgem.com/2017/08/16/cutera-inc-cutr-evp-ronald-j-santilli-sells-1068-shares.html.

Several equities analysts have weighed in on the company. BidaskClub upgraded Cutera from a “hold” rating to a “buy” rating in a report on Saturday. Gabelli restated a “buy” rating on shares of Cutera in a report on Wednesday, August 9th. Roth Capital raised their target price on Cutera from $32.00 to $39.00 and gave the company a “buy” rating in a report on Tuesday, August 8th. Zacks Investment Research lowered Cutera from a “buy” rating to a “hold” rating in a report on Monday, June 26th. Finally, Sidoti restated a “buy” rating and set a $30.00 target price (up from $27.00) on shares of Cutera in a report on Saturday, June 3rd. Six analysts have rated the stock with a buy rating, The company presently has a consensus rating of “Buy” and a consensus target price of $33.25.

Several large investors have recently modified their holdings of CUTR. Kennedy Capital Management Inc. purchased a new stake in shares of Cutera during the second quarter worth about $9,426,000. Stonepine Capital Management LLC purchased a new stake in shares of Cutera during the second quarter worth about $4,533,000. Renaissance Technologies LLC boosted its stake in shares of Cutera by 13.4% in the first quarter. Renaissance Technologies LLC now owns 1,205,400 shares of the medical device company’s stock worth $24,952,000 after buying an additional 142,140 shares during the last quarter. Summit Creek Advisors LLC purchased a new stake in shares of Cutera during the second quarter worth about $3,380,000. Finally, Ameriprise Financial Inc. purchased a new stake in shares of Cutera during the second quarter worth about $3,175,000. 84.44% of the stock is currently owned by institutional investors.

About Cutera

Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.

Insider Buying and Selling by Quarter for Cutera (NASDAQ:CUTR)

Receive News & Stock Ratings for Cutera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera Inc. and related stocks with our FREE daily email newsletter.